Hope, Quality of Life, and Benefit From Treatment in Women Having Chemotherapy for Platinum-Resistant/Refractory Recurrent Ovarian Cancer: The Gynecologic Cancer Intergroup Symptom Benefit Study

PURPOSE. Chemotherapy for platinum-resistant/refractory ovarian cancer is motivated by the hope of benefit. We sought to determine the relationships between: (a) trait hope, expectation of symptom benefit from chemotherapy, and anxiety and depression; (b) hope and perceived efficacy of chemotherapy;...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Sjoquist, Katrin M., Friedlander, Michael L., O'Connell, Rachel L., Voysey, Merryn, King, Madeleine T., Stockler, Martin R., Oza, Amit M., Gillies, Kim, Martyn, Julie K., Butow, Phyllis N.
التنسيق: Artigo
اللغة:Inglês
منشور في: AlphaMed Press 2013
الموضوعات:
Symptom Management and Supportive Care
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC3825308/
https://ncbi.nlm.nih.gov/pubmed/24107972
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2013-0175
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة